Seeking Alpha

St. Jude Medical (STJ +1.4%) gains on the back of yesterday's $1B buyback announcement and an...

St. Jude Medical (STJ +1.4%) gains on the back of yesterday's $1B buyback announcement and an upgrade to Buy at Mizuho. The firm says that concerns about a Durata recall are overblown, and that any impact on its EPS from market share loss in implanted defibrillators should be "more than offset" by yesterday's buyback announcement.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)